TREATMENT OF ANEMIA RESISTANT TO CONVENTIONAL ERYTHROPOIETIN THERAPY WITH THYMOPENTIN IN HEMODIALYSIS-PATIENTS

被引：3

作者：

RAIOLA, P ^{[1
]}

MANZO, M ^{[1
]}

SAGGESE, A ^{[1
]}

TOMASINO, G ^{[1
]}

CICCHELLA, T ^{[1
]}

RAMBALDI, M ^{[1
]}

PISANO, M ^{[1
]}

LIZZA, B ^{[1
]}

PERNA, AF ^{[1
]}

机构：

[1] UNIV NAPLES 2,SCH MED,DEPT PEDIAT,CHAIR NEPHROL,NAPLES,ITALY

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 1995年 / 10卷

关键词：

CHRONIC RENAL FAILURE; RESISTANT ANEMIA; ERYTHROPOIETIN; THYMOPENTIN;

D O I：

10.1093/ndt/10.supp6.48

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：48 / 50

页数：3

共 50 条

[31] THE EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON HEMOSTASIS AND FIBRINOLYSIS IN HEMODIALYSIS-PATIENTS
WIRTZ, JJJM
VANESSER, JWJ
HAMULYAK, K
LEUNISSEN, KML
VANHOOFF, JP
CLINICAL NEPHROLOGY, 1992, 38 (05) : 277 - 282
[32] HYPOFIBRINOLYSIS AFTER STIMULATION BY VENOUS OCCLUSION IN HEMODIALYSIS-PATIENTS AND THE EFFECT OF ERYTHROPOIETIN
OPATRNY, K
VIT, L
OPATRNA, S
BODLAKOVA, B
SULKOVA, S
OPATRNY, K
NIEREN-UND HOCHDRUCKKRANKHEITEN, 1995, 24 (07) : 324 - 328
[33] IRON-METABOLISM INDEXES FOR EARLY PREDICTION OF THE RESPONSE AND RESISTANCE TO ERYTHROPOIETIN THERAPY IN MAINTENANCE HEMODIALYSIS-PATIENTS
TARNG, DC
CHEN, TW
HUANG, TP
AMERICAN JOURNAL OF NEPHROLOGY, 1995, 15 (03) : 230 - 237
[34] Use of intravenous iron without erythropoietin for the treatment of anemia of hemodialysis
Alvo, M
Elgueta, L
Aragón, H
Cotera, A
REVISTA MEDICA DE CHILE, 2002, 130 (08) : 865 - 868
[35] PAIN AT THE INJECTION SITE OF SUBCUTANEOUSLY ADMINISTERED ERYTHROPOIETIN IN MAINTENANCE HEMODIALYSIS-PATIENTS - A COMPARISON OF 2 BRANDS OF ERYTHROPOIETIN
VEYS, N
VANHOLDER, R
LAMEIRE, N
AMERICAN JOURNAL OF NEPHROLOGY, 1992, 12 (1-2) : 68 - 72
[36] BIOAVAILABILITY OF IRON IN HEMODIALYSIS-PATIENTS TREATED WITH ERYTHROPOIETIN - EVIDENCE FOR THE INHIBITORY ROLE OF ALUMINUM
DONNELLY, SM
ALI, MAM
CHURCHILL, DN
AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 16 (05) : 447 - 451
[37] EVALUATION OF PLATELET HYPERFUNCTION IN HEMODIALYSIS-PATIENTS RECEIVING RECOMBINANT-HUMAN-ERYTHROPOIETIN
ZIRKMAN, DM
ZEIGLER, ZR
FRALEY, DS
BRUNS, FJ
ADLER, S
AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (01) : 31 - 37
[38] NUTRITIONAL ASSESSMENT IN ANEMIC HEMODIALYSIS-PATIENTS TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
BARANY, P
PETTERSON, E
AHLBERG, M
HULTMAN, E
BERGSTROM, J
CLINICAL NEPHROLOGY, 1991, 35 (06) : 270 - 279
[39] IMPROVEMENT OF ERYTHROPOIETIN-INDUCED HYPERTENSION IN HEMODIALYSIS-PATIENTS CHANGING THE ADMINISTRATION ROUTE
NAVARRO, JF
TERUEL, JL
MARCEN, R
ORTUNO, J
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1995, 29 (01): : 11 - 14
[40] ONCE WEEKLY VERSUS TWICE WEEKLY SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN HEMODIALYSIS-PATIENTS
LUI, SF
WONG, KC
LI, PKT
LAI, KN
AMERICAN JOURNAL OF NEPHROLOGY, 1992, 12 (1-2) : 55 - 60

← 1 2 3 4 5 →